Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles.

PURPOSE To identify the muscarinic acetylcholine receptor subtype that mediates cholinergic vasodilation in murine retinal arterioles. METHODS Muscarinic receptor gene expression was determined in murine retinal arterioles using real-time PCR. To assess the functional relevance of muscarinic receptors for mediating vascular responses, retinal vascular preparations from muscarinic receptor-deficient mice were studied in vitro. Changes in luminal arteriole diameter in response to muscarinic and nonmuscarinic vasoactive substances were measured by video microscopy. RESULTS Only mRNA for the M(3) receptor was detected in retinal arterioles. Thus, M(3) receptor-deficient mice (M3R(-/-)) and respective wild-type controls were used for functional studies. Acetylcholine concentration-dependently dilated retinal arterioles from wild-type mice. In contrast, vasodilation to acetylcholine was almost completely abolished in retinal arterioles from M3R(-/-) mice, whereas responses to the nitric oxide (NO) donor nitroprusside were retained. Carbachol, an acetylcholinesterase-resistant analog of acetylcholine, also evoked dilation in retinal arterioles from wild-type, but not from M3R(-/-), mice. Vasodilation responses from wild-type mice to acetylcholine were negligible after incubation with the non-subtype-selective muscarinic receptor blocker atropine or the NO synthase inhibitor N(ω)-nitro-L-arginine methyl ester, and were even reversed to contraction after endothelial damage with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate. CONCLUSIONS These findings provide evidence that endothelial M(3) receptors mediate cholinergic vasodilation in murine retinal arterioles via activation of NO synthase.

[1]  D. R. Anderson,et al.  Biochemical evidence for cholinergic activity in retinal blood vessels. , 1989, Investigative ophthalmology & visual science.

[2]  N. F. Dabhoiwala,et al.  Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  J. Wess,et al.  Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice. , 2009, Investigative ophthalmology & visual science.

[4]  M. Wolzt,et al.  Propranolol and atropine do not alter choroidal blood flow regulation during isometric exercise in healthy humans. , 2003, Microvascular research.

[5]  J. Skupień,et al.  Retinopathy in type 2 diabetes mellitus is associated with increased intima‐media thickness and endothelial dysfunction , 2008, European journal of clinical investigation.

[6]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[7]  A. Laties Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. , 1967, Archives of ophthalmology.

[8]  M J HOGAN,et al.  THE ULTRASTRUCTURE OF THE RETINAL BLOOD VESSELS. I. THE LARGE VESSELS. , 1963, Journal of ultrastructure research.

[9]  C. Sigmund,et al.  Vascular biology in genetically altered mice : smaller vessels, bigger insight. , 1999, Circulation research.

[10]  L. Schmetterer,et al.  Effects of Atropine and Propranolol on Retinal Vessel Diameters during Isometric Exercise , 2001, Ophthalmic Research.

[11]  E. Hamel,et al.  Muscarinic—but Not Nicotinic—Acetylcholine Receptors Mediate a Nitric Oxide-Dependent Dilation in Brain Cortical Arterioles: A Possible Role for the M5 Receptor Subtype , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  Zhen-Yu Chen,et al.  Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery. , 2006, Vascular pharmacology.

[13]  J. Wess,et al.  Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. , 2004, Annual review of pharmacology and toxicology.

[14]  A. Jovanovic,et al.  Muscarinic Receptor Subtypes Mediating Vasorelaxation of the Perforating Branch of the Human Internal Mammary Artery , 2001, Pharmacology.

[15]  J. Wess,et al.  Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Saito,et al.  Vasodilator effects of adenosine on retinal arterioles in streptozotocin-induced diabetic rats , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  G. Barnes,et al.  A novel method to assess reactivities of retinal microcirculation. , 1994, Microvascular research.

[18]  R H Masland,et al.  The shape and arrangement of the cholinergic neurons in the rabbit retina , 1984, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[19]  S. Benedito,et al.  Role of the endothelium in acetylcholine-induced relaxation and spontaneous tone of bovine isolated retinal small arteries. , 1991, Experimental eye research.

[20]  R H Masland,et al.  Acetylcholine-synthesizing amacrine cells: identification and selective staining by using radioautography and fluorescent markers , 1984, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[21]  T. Ohhashi,et al.  Development of pressurized retinal resistance-sized arteriolar preparation with special reference to acetylcholine-induced nitric-oxide-mediated vasodilatation. , 2002, The Japanese journal of physiology.

[22]  A. Cohen,et al.  Choline acetyltransferase and acetylcholine esterase activities in normal and biologically fractionated mouse retinas. , 1975, Investigative Ophthalmology.

[23]  D. Puro,et al.  Cholinergic regulation of pericyte-containing retinal microvessels. , 2003, American journal of physiology. Heart and circulatory physiology.

[24]  R. Stone,et al.  Nitric oxide and choroidal blood flow regulation. , 1995, Investigative ophthalmology & visual science.

[25]  M. Kirschenbaum,et al.  A rapid method for isolating rabbit renal microvessels. , 1988, The American journal of physiology.

[26]  G. Duncan,et al.  Role of the non-neuronal cholinergic system in the eye: a review. , 2003, Life sciences.

[27]  A. Reiner,et al.  Role of muscarinic cholinergic transmission in Edinger-Westphal nucleus-induced choroidal vasodilation in pigeon. , 2000, Experimental eye research.

[28]  L. Schmetterer,et al.  Changes in choroidal blood flow during light/dark transitions are not altered by atropine or propranolol in healthy subjects , 2003, Vision Research.

[29]  N. Birdsall,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[30]  M. Koss,et al.  Long posterior ciliary arterial blood flow and systemic blood pressure. , 1990, Investigative ophthalmology & visual science.

[31]  P. Chang,et al.  In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. , 1994, Circulation research.

[32]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[33]  B. Sastry Cholinergic systems and multiple cholinergic receptors in ocular tissues. , 1985, Journal of ocular pharmacology.

[34]  A. Yamanaka,et al.  Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean , 2001, Nature.

[35]  N. F. Dabhoiwala,et al.  Lack of Specificity of Commercially Available Antisera: Better Specifications Needed , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  Christian C. Felder,et al.  Muscarinic Acetylcholine Receptor Knockout Mice , 2004 .

[37]  J. Wess,et al.  Muscarinic (M) Receptors in Coronary Circulation Gene-Targeted Mice Define the Role of M2 and M3 Receptors in Response to Acetylcholine , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Richard M. Eglen,et al.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development , 2007, Nature Reviews Drug Discovery.

[39]  L. Andries,et al.  Contractile responses of isolated bovine retinal microarteries to acetylcholine. , 1991, Investigative ophthalmology & visual science.

[40]  R. Eglen,et al.  The muscarinic M5 receptor: a silent or emerging subtype? , 2000, British journal of pharmacology.

[41]  J. Phillips,et al.  Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. , 1997, Journal of the autonomic nervous system.

[42]  M. H. Shaikh,et al.  The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension , 2001, Eye.

[43]  Wolfgang Kummer,et al.  Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  Leopold Schmetterer,et al.  Endothelial dysfunction in glaucoma , 2009, Acta ophthalmologica.